Liver immunology and its role in inflammation and homeostasis

Cellular and Molecular Immunology

Volumn 13, Issue 3, 2016, Pages 267-276

  Robinson, Mark W ^a   Harmon, Cathal ^a   O'Farrelly, Cliona ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

homeostasis; immunology; inflammation; liver; tolerance

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; PATTERN RECOGNITION RECEPTOR; PLASMA PROTEIN; TICILIMUMAB; TOLL LIKE RECEPTOR;

ACUTE PHASE RESPONSE; ANTIGEN PRESENTING CELL; BONE MARROW CELL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG TARGETING; HEMATOPOIETIC STEM CELL; HEPATITIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER METABOLISM; LIVER REGENERATION; LIVER STRUCTURE; LYMPHOID CELL; MICROENVIRONMENT; MYELOID DENDRITIC CELL; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOLOGICAL MODEL; HOMEOSTASIS; IMMUNOLOGY; INFLAMMATION; LIVER; LIVER DISEASES; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; CELLULAR MICROENVIRONMENT; HOMEOSTASIS; HUMANS; INFLAMMATION; LIVER; LIVER DISEASES; MODELS, BIOLOGICAL;

EID: 84966311104     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2016.3     Document Type: Review

References (112)

1. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27: 147-163.
2. Nemeth E, Baird AW, OFarrelly C. Microanatomy of the liver immune system. Semin Immunopathol 2009; 31: 333-343.
3. OFarrelly C, Crispe IN. Prometheus through the looking glass: reflections on the hepatic immune system. Immunol Today 1999; 20: 394-398.
4. Thouas GA, Dominguez F, Green MP, Vilella F, Simon C, Gardner DK. Soluble ligands and their receptors in human embryo development and implantation. Endocr Rev 2015; 36: 92-130.
5. Wang J, Knaut H. Chemokine signaling in development and disease. Development 2014; 141: 4199-4205.
6. Leoni G, Neumann P-A, Sumagin R, Denning TL, Nusrat A. Wound repair: role of immune-epithelial interactions. Mucosal Immunol 2015; 8: 959-968.
7. Janeway CA. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992; 13: 11-16.
8. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
9. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012; 143: 1158-1172.
10. Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbé E et al. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 1996; 24: 100-111.
11. Kelly A, Fahey R, Fletcher JM, Keogh C, Carroll AG, Siddachari R et al. CD141+ myeloid dendritic cells are enriched in healthy human liver. J Hepatol 2014; 60: 135-142.
12. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999; 163: 2314-2321.
13. Norris S, Collins C, Doherty DG, Smith F, McEntee G, Traynor O et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998; 28: 84-90.
14. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175-1186.
15. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH et al. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 2000; 31: 932-936.
16. Schieferdecker HL, Schlaf G, Jungermann K, Götze O. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int Immunopharmacol 2001; 1: 469-481.
17. van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G et al. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000; 6: 680-685.
18. Elsegood CL, Chan CW, Degli-Esposti MA, Wikstrom ME, Domenichini A, Lazarus K et al. Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology 2015; 62: 1272-1284.
19. Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 2010; 129: 363-374.
20. Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E. Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 2013; 57: 577-589.
21. Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010; 10: 753-766.
22. Chen S, Akbar SMF, Abe M, Hiasa Y, Onji M. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 2011; 166: 134-142.
23. Pallett LJ, Gill US, Quaglia A, Sinclair L V, Jover-Cobos M, Schurich A et al. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med 2015; 21: 591-600.
24. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
25. Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 1996; 157: 2514-2520.
26. Kenna T, Golden-Mason L, Norris S, Hegarty JE, OFarrelly C, Doherty DG. Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver. Clin Immunol 2004; 113: 56-63.
27. Kenna T, Golden-Mason L, Porcelli SA, Koezuka Y, Hegarty JE, OFarrelly C et al. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 2003; 171: 1775-1779.
28. Dusseaux M, Martin E, Serriari N, Péguillet I, Premel V, Louis D et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011; 117: 1250-1259.
29. Gao B, Jeong W-I, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47: 729-736.
30. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Natural killer activity of human liver-derived lymphocytes in various liver diseases. Hepatology 1991; 14: 495-503.
31. Moroso V, Metselaar HJ, Mancham S, Tilanus HW, Eissens D, van der Meer A et al. Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl 2010; 16: 895-908.
32. Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat Immunol 2015; 16: 85-95.
33. Pruvot FR, Navarro F, Janin A, Labalette M, Masy E, Lecomte-Houcke M et al. Characterization, quantification, and localization of passenger T lymphocytes and NK cells in human liver before transplantation. Transpl Int 1995; 8: 273-279.
34. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999; 163: 3202-3210.
35. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994; 1: 741-749.
36. Racanelli V, Sansonno D, Piccoli C, DAmore FP, Tucci FA, Dammacco F. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001; 167: 21-29.
37. Curry MP, Golden-Mason L, Doherty DG, Deignan T, Norris S, Duffy M et al. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 2003; 38: 642-650.
38. Golden-Mason L, Curry MP, Nolan N, Traynor O, McEntee G, Kelly J et al. Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver. Hepatology 2000; 31: 1251-1256.
39. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, OFarrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999; 29: 1193-1198.
40. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996; 2: 198-203.
41. Jiang X, Chen Y, Wei H, Sun R, Tian Z. Characterizing the lymphopoietic kinetics and features of hematopoietic progenitors contained in the adult murine liver in vivo. PLoS One 2013; 8: e76762.
42. Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol 2013; 14: 996-1006.
43. Seki E, Brenner D. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335.
44. Böttcher JP, Schanz O, Wohlleber D, Abdullah Z, Debey-Pascher S, Staratschek-Jox A et al. Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity. Cell Rep 2013; 3: 779-795.
45. Yang L, Jhaveri R, Huang J, Qi Y, Diehl AM. Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. Lab Invest 2007; 87: 927-937.
46. Yanagisawa K, Yue S, van der Vliet HJ, Wang R, Alatrakchi N, Golden- Mason L et al. Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. J Viral Hepat 2013; 20: 556-565.
47. Kelly AM, Golden-Mason L, Traynor O, Geoghegan J, McEntee G, Hegarty JE et al. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: implications for hepatic anti-tumour immunity. Cytokine 2006; 35: 171-179.
48. Golden-Mason L, Kelly AM, Doherty DG, Traynor O, McEntee G, Kelly J et al. Hepatic interleuklin 15 (IL-15) expression: implications for local NK/NKT cell homeostasis and development. Clin Exp Immunol 2004; 138: 94-101.
49. Tu Z, Bozorgzadeh A, Crispe IN, Orloff MS. The activation state of human intrahepatic lymphocytes. Clin Exp Immunol 2007; 149: 186-193.
50. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013; 496: 238-242.
51. Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol 2015; 15: 104-116.
52. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-1846.
53. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011; 54: 133-144.
54. Filipe A, McLauchlan J. Hepatitis C virus and lipid droplets: finding a niche. Trends Mol Med 2015; 21: 34-42.
55. Bar-Yishay I, Shaul Y, Shlomai A. Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int 2011; 31: 282-290.
56. ONeill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med 2015; 213: 15-23.
57. Wilson GK, Tennant DA, McKeating JA. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J Hepatol 2014; 61: 1397-1406.
58. Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol 2012; 12: 201-213.
59. Crispe IN. Immune tolerance in liver disease. Hepatology 2014; 60: 2109-2117.
60. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
61. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006; 6: 1774-1780.
62. Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong T-L. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database. Transplantation 2006; 82: 1298-1303.
63. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Büschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995; 22: 226-229.
64. Callery MP, Mangino MJ, Flye MW. Kupffer cell prostaglandin-E2 production is amplified during hepatic regeneration. Hepatology 1991; 14: 368-372.
65. Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184: 19-29.
66. Knolle PA, Uhrig A, Hegenbarth S, Löser E, Schmitt E, Gerken G et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998; 114: 427-433.
67. Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 2015; 62: 279-291.
68. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005; 174: 2037-2045.
69. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP et al. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 2009; 182: 1901-1911.
70. Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004; 164: 511-519.
71. Kingham TP, Chaudhry UI, Plitas G, Katz SC, Raab J, DeMatteo RP. Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion. Hepatology 2007; 45: 445-454.
72. Tokita D, Sumpter TL, Raimondi G, Zahorchak AF, Wang Z, Nakao A et al. Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol 2008; 49: 1008-1018.
73. Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H. Hepatic stellate cells function as regulatory bystanders. J Immunol 2011; 186: 5549-5555.
74. Wuensch SA, Spahn J, Crispe IN. Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes. Hepatology 2010; 52: 1068-1077.
75. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-712.
76. Zimmermann HW, Bruns T, Weston CJ, Curbishley SM, Liaskou E, Li K-K et al. Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver. Hepatology 2015; 63: 233-246.
77. Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Müller M et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207: 1453-1464.
78. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181: 257-266.
79. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
80. Zhou Z, Xu M-J, Gao B. Hepatocytes: a key cell type for innate immunity. Cell Mol Immunol 2015; e-pub ahead of print 21 December 2015; doi:10. 1038/cmi. 2015. 97.
81. Inatsu A, Kinoshita M, Nakashima H, Shimizu J, Saitoh D, Tamai S et al. Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity. Hepatology 2009; 49: 2044-2054.
82. Gregory SH, Wing EJ. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 2002; 72: 239-248.
83. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer Cells reduced CXC chemokine production and liver injury. J Surg Res 2001; 99: 201-210.
84. Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med 2008; 205: 233-244.
85. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 2014; 14: 181-194.
86. Bourbonnais E, Raymond V-A, Ethier C, Nguyen BN, El-Leil MS, Meloche S et al. Liver fibrosis protects mice from acute hepatocellular injury. Gastroenterology 2012; 142: 130-139. e4.
87. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999; 30: 77-87.
88. Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA 2012; 109: E3186-E3195.
89. Glässner A, Eisenhardt M, Krämer B, Körner C, Coenen M, Sauerbruch T et al. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab Invest 2012; 92: 967-977.
90. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosisinducing ligand-dependent manners. Gastroenterology 2006; 130: 435-452.
91. Malato Y, Naqvi S, Schürmann N, Ng R, Wang B, Zape J et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 2011; 121: 4850-4860.
92. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286-300.
93. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383.
94. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263: G579-G585.
95. Rai RM, Lee FY, Rosen A, Yang SQ, Lin HZ, Koteish A et al. Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci USA 1998; 95: 13829-13834.
96. Selzner N, Selzner M, Odermatt B, Tian Y, Van Rooijen N, Clavien P-A. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 2003; 124: 692-700.
97. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003; 198: 913-923.
98. Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009; 86: 513-528.
99. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004; 127: 1525-1539.
100. Shen K, Zheng S-S, Park O, Wang H, Sun Z, Gao B. Activation of innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1070-G1077.
101. Dong Z, Zhang J, Sun R, Wei H, Tian Z. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007; 45: 1400-1412.
102. Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 2015; 61: 1066-1079.
103. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009; 50: 261-274.
104. Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol 2015; 63: 1272-1284.
105. Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol 2014; 60: 210-223.
106. Kedarisetty CK, Anand L, Bhardwaj A, Bhadoria AS, Kumar G, Vyas AK et al. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology 2015; 148: 1362-70. e7.
107. Makarova-Rusher OV, Medina-Echeverz J, Duffy AG, Greten TF. The yin and yang of evasion and immune activation in HCC. J Hepatol 2015; 62: 1420-1429.
108. Kitamura T, Qian B-Z, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol 2015; 15: 73-86.
109. Saeed S, Quintin J, Kerstens HHD, Rao NA, Aghajanirefah A, Matarese F et al. Epigenetic programming of monocyte-tomacrophage differentiation and trained innate immunity. Science 2014; 345: 1251086-1251086.
110. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol 2014; 14: 36-49.
111. Park S-H, Rehermann B. Immune responses to HCV and other hepatitis viruses. Immunity 2014; 40: 13-24.
112. Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garraluda E, Barrera P et al. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. J Hepatol 2013; 59: 81-88.